Results

Total Results: 389 records

Showing results for "operate alkaloids".

101. Learning from preventable deaths: exploring case record reviewers' narratives using change analysis. | PSNet
     psnet.ahrq.gov/issue/learning-preventable-deaths-exploring-case-record-reviewers-narratives-using-change-analysis
     August 01, 2012 - the pathway to a catastrophic event: an analysis of national incident report data relating to vinca alkaloids

102. FDA Safety Communication: recommendations to reduce surgical fires and related patient injury. | PSNet
     psnet.ahrq.gov/issue/fda-safety-communication-recommendations-reduce-surgical-fires-and-related-patient-injury
     February 07, 2018 - Press Release/Announcement FDA Safety Communication: recommendations to reduce surgical fires and related patient injury. Citation Text: MedWatch Safety Alert. Silver Spring, MD: US Food and Drug Administration. May 29, 2018. Copy Citation Save Save to your librar…

103. Survey of the national drug shortage effect on anesthesia and patient safety: a patient perspective. | PSNet
     psnet.ahrq.gov/issue/survey-national-drug-shortage-effect-anesthesia-and-patient-safety-patient-perspective
     October 20, 2010 - the pathway to a catastrophic event: an analysis of national incident report data relating to vinca alkaloids

104. Using an enhanced oral chemotherapy computerized provider order entry system to reduce prescribing errors and improve safety. | PSNet
     psnet.ahrq.gov/issue/using-enhanced-oral-chemotherapy-computerized-provider-order-entry-system-reduce-prescribing
     September 03, 2014 - Study Using an enhanced oral chemotherapy computerized provider order entry system to reduce prescribing errors and improve safety. Citation Text: Collins CM, Elsaid KA. Using an enhanced oral chemotherapy computerized provider order entry system to reduce prescribing errors and improve …

105. Exploring the harmful effects of health care. | PSNet
     psnet.ahrq.gov/issue/exploring-harmful-effects-health-care
     January 25, 2023 - the pathway to a catastrophic event: an analysis of national incident report data relating to vinca alkaloids

106. Safety analysis over time: seven major changes to adverse event investigation. | PSNet
     psnet.ahrq.gov/issue/safety-analysis-over-time-seven-major-changes-adverse-event-investigation
     April 11, 2018 - the pathway to a catastrophic event: an analysis of national incident report data relating to vinca alkaloids

107. Measurement and monitoring of safety: impact and challenges of putting a conceptual framework into practice. | PSNet
     psnet.ahrq.gov/issue/measurement-and-monitoring-safety-impact-and-challenges-putting-conceptual-framework-practice
     January 24, 2018 - the pathway to a catastrophic event: an analysis of national incident report data relating to vinca alkaloids

108. Safer healthcare at home: detecting, correcting and learning from incidents involving infusion devices. | PSNet
     psnet.ahrq.gov/issue/safer-healthcare-home-detecting-correcting-and-learning-incidents-involving-infusion-devices
     June 06, 2018 - Study Safer healthcare at home: detecting, correcting and learning from incidents involving infusion devices. Citation Text: Lyons I, Blandford A. Safer healthcare at home: detecting, correcting and learning from incidents involving infusion devices. App Ergon. 2018;67(Feb):104-114. doi:…

109. Learning from failure: the need for independent safety investigation in healthcare. | PSNet
     psnet.ahrq.gov/issue/learning-failure-need-independent-safety-investigation-healthcare
     April 11, 2018 - the pathway to a catastrophic event: an analysis of national incident report data relating to vinca alkaloids

110. Addressing the Global Shortages of Medicines, and the Safety and Accessibility of Children's Medication. | PSNet
     psnet.ahrq.gov/issue/addressing-global-shortages-medicines-and-safety-and-accessibility-childrens-medication
     October 12, 2011 - September 6, 2023 Vincristine (and other vinca alkaloids) should only be given intravenously

111. Conversations with...Lucian Leape, MD. | PSNet
     psnet.ahrq.gov/issue/conversations-withlucian-leape-md
     December 11, 2013 - March 6, 2005 Death and neurological devastation from intrathecal vinca alkaloids: prepared

112. Using patient safety science to explore strategies for improving safety in intravenous medication administration. | PSNet
     psnet.ahrq.gov/issue/using-patient-safety-science-explore-strategies-improving-safety-intravenous-medication
     September 06, 2006 - Commentary Using patient safety science to explore strategies for improving safety in intravenous medication administration. Citation Text: Franklin M. Journal of the Association for Vascular Access. 2006. 11(3):157–160. Copy Citation Save Save to your library …

113. Medication Safety and Hospital Referrals: A Report by the Health and Disability Commissioner. | PSNet
     psnet.ahrq.gov/issue/medication-safety-and-hospital-referrals-report-health-and-disability-commissioner
     April 11, 2007 - November 6, 2013 Vincristine (and other vinca alkaloids) should only be given intravenously

114. Make no mistake about it: chain pharmacies are finding innovative ways to combat medication errors. | PSNet
     psnet.ahrq.gov/issue/make-no-mistake-about-it-chain-pharmacies-are-finding-innovative-ways-combat-medication
     August 15, 2007 - July 10, 2015 Vincristine (and other vinca alkaloids) should only be given intravenously

115. Ethical Issues in Patient Safety Research: Interpreting Existing Guidance. | PSNet
     psnet.ahrq.gov/issue/ethical-issues-patient-safety-research-interpreting-existing-guidance
     July 13, 2016 - January 30, 2013 Vincristine (and other vinca alkaloids) should only be given intravenously

116. EHC Research Protocol (Amended): Treatments for Acute Episodic Migraine (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/migraine-treatments-research-amended-protocol.pdf
     January 09, 2020 - month for greater than 3 months) and days of use per month of specific medications.8 Triptans, ergots alkaloids … pharmacologic therapy (e.g., acetaminophen, nonsteroidal anti-inflammatory drugs [NSAIDs], triptans, ergots alkaloids … pharmacologic therapy (e.g., acetaminophen, nonsteroidal anti-inflammatory drugs [NSAIDs], triptans, ergots alkaloids … Inclusion Criteria Exclusion Criteria • Triptans (if compared against active treatment) • Ergots alkaloids

117. Patient-safety–related hospital deaths in England: thematic analysis of incidents reported to a national database, 2010–2012. | PSNet
     psnet.ahrq.gov/issue/patient-safety-related-hospital-deaths-england-thematic-analysis-incidents-reported-national
     February 26, 2014 - the pathway to a catastrophic event: an analysis of national incident report data relating to vinca alkaloids

118. Evidence-based interventions to reduce adverse events in hospitals: a systematic review of systematic reviews. | PSNet
     psnet.ahrq.gov/issue/evidence-based-interventions-reduce-adverse-events-hospitals-systematic-review-systematic
     March 18, 2015 - the pathway to a catastrophic event: an analysis of national incident report data relating to vinca alkaloids

119. The effect of an electronic SBAR communication tool on documentation of acute events in the pediatric intensive care unit. | PSNet
     psnet.ahrq.gov/issue/effect-electronic-sbar-communication-tool-documentation-acute-events-pediatric-intensive-care
     August 12, 2015 - the pathway to a catastrophic event: an analysis of national incident report data relating to vinca alkaloids

120. Using a survey of incident reporting and learning practices to improve organisational learning at a cancer care centre. | PSNet
     psnet.ahrq.gov/issue/using-survey-incident-reporting-and-learning-practices-improve-organisational-learning-cancer
     February 04, 2009 - the pathway to a catastrophic event: an analysis of national incident report data relating to vinca alkaloids